Today: 30 April 2026
Qualcomm stock edges higher in thin year-end trade as Fed minutes land — what to watch next
31 December 2025
1 min read

Qualcomm stock edges higher in thin year-end trade as Fed minutes land — what to watch next

NEW YORK, December 30, 2025, 21:28 ET — Market closed

Qualcomm Incorporated shares finished modestly higher on Tuesday, closing up 0.22 points, or 0.13%, at $173.65.

The small gain came as Wall Street ended slightly lower in choppy, holiday-thinned trading. The Dow fell 0.20%, the S&P 500 slipped 0.14% and the Nasdaq lost 0.23%, while Apple fell 0.3% and Nvidia dropped 0.4%, according to Reuters. Mark Hackett, chief market strategist at Nationwide, said: “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off.” Reuters

Why this matters now: late-December positioning can move chip stocks even when there is little company-specific news, because many investors treat semiconductors as a high-beta proxy for the technology trade. The Fed’s policy outlook also matters, as rate expectations often influence valuations for growth-oriented shares.

Investors on Tuesday also parsed the Federal Reserve’s meeting minutes — the detailed account of its December policy discussions — released at 2:00 p.m. EST.

Qualcomm, a major supplier of modem chips and Snapdragon processors used in smartphones, has been trading near the mid-$170s into year-end as investors weigh a 2026 demand outlook against a shifting competitive landscape.

The broader tape has been sensitive to moves in mega-cap tech and AI-linked names, with Nvidia’s pullback weighing on sentiment across parts of the semiconductor space. Qualcomm’s shares held steadier than some higher-momentum chip trades during Tuesday’s session.

The company’s most recent financial update came in early November, when it forecast quarterly sales and profit above market estimates as premium smartphone demand improved, Reuters reported. Qualcomm also warned of a possible loss of business next year from Samsung, a key customer, which weighed on the stock after hours at the time.

Qualcomm has been pushing to diversify beyond phones. In late October, it unveiled two artificial intelligence chips for data centers and related rack systems aimed at “inference,” the process of running AI models in production, and its shares surged on the announcement, Reuters said. Reuters

Investors remain focused on how quickly newer businesses can scale, while the company prepares for Apple’s longer-term shift away from Qualcomm as a modem supplier, a structural risk that has periodically pressured the stock, Reuters has reported.

Before the next session, traders will watch whether year-end rotation continues and whether rate-sensitive tech extends its pullback after the Fed minutes. The Fed’s calendar shows its next policy meeting is scheduled for Jan. 27–28, 2026.

The next major Qualcomm-specific catalyst is its fiscal first-quarter earnings conference call, scheduled for Feb. 4, 2026 at 1:45 p.m. PT, according to the company’s investor events page.

Heading into that report, investors are likely to scrutinize guidance on handset chip demand and licensing revenue, along with updates on automotive and IoT momentum and any commentary tied to major customers. In the near term, traders will also watch whether QCOM can hold the $170–$173 area on pullbacks and reclaim levels near $175 as positioning shifts into early 2026.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Cisco stock slips in year-end trade as Fed minutes keep CSCO investors cautious
Previous Story

Cisco stock slips in year-end trade as Fed minutes keep CSCO investors cautious

Al-Arafah Islami Bank, Provati Insurance sign deal to digitise premium payments in Bangladesh
Next Story

Al-Arafah Islami Bank, Provati Insurance sign deal to digitise premium payments in Bangladesh

Go toTop